Dr. Neil Floch to Lead Bariatric Surgery at Greenwich
Yale Medicine is pleased to announce the recruitment of Dr. Neil Floch as Director of Bariatric Surgery at Greenwich Hospital, effective May 2023.
Related Articles
Vacation Days Taken, Work During Vacation, and Burnout Among US Physicians
This cross-sectional study examines the number of vacation days taken per year and the magnitude of physician work while on vacation and their association with…
The Necessary Scale for Obesity Care and Population Health – ConscienHealth
Should we be comfortable with the present limited scale of obesity care that makes it a luxury few people can access?
Researchers identify causal genetic variant linked to common childhood obesity
Researchers from Children’s Hospital of Philadelphia (CHOP) have identified a causal genetic variant strongly associated with childhood obesity. The study provides new insight into the…
The effects of dietary macronutrient composition on resting energy expenditure following active weight loss: A systematic review and meta‐analysis
A systematic review and meta-analysis was conducted to evaluate the relative effectiveness of different dietary macronutrient patterns on changes in resting energy expenditure (REE) in…
A sum greater than its parts: Time-restricted eating and high-intensity exercise work together to improve health
Combining time-restricted eating with high-intensity functional training may improve body composition and cardiometabolic parameters more than either alone, according to a study published May 1,…
Researchers identify causal genetic variant linked to common childhood obesity
Researchers from Children’s Hospital of Philadelphia (CHOP) have identified a causal genetic variant strongly associated with childhood obesity. The study provides new insight into the…
So, you’ve lost weight using Wegovy. Does that mean you can stop taking it?
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if…
Small Bowel Microbiome Profiles Differ in Overweight/Obesity vs Normal Weight
Researchers have identified significant and specific variations in the microbial universe of the small intestine in overweight or obese adults compared with normal-weight peers.
The Affordable Care Act: An Overview of the Evidence
RAND researchers have analyzed the Patient Protection and Affordable Care Act—the sweeping health care reform sometimes known as “Obamacare”—from many different angles. Here’s what they’ve…
Amgen goes all in on injectable obesity drug as it scraps early-stage pill
Amgen said that it will no longer develop an early-stage obesity pill, and will instead focus on an injectable candidate that’s seen as a potential…